[EN] INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS D'INDOLÉAMINE 2,3-DIOXYGÉNASE ET LEURS PROCÉDÉS D'UTILISATION
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2019136112A1
公开(公告)日:2019-07-11
The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed.
Mamedov,S. et al., Journal of general chemistry of the USSR, 1962, vol. 32, p. 3567 - 3571
作者:Mamedov,S. et al.
DOI:——
日期:——
BAGDASARYAN G. B.; AJRIYAN L. SH.; BADALYAN K. S.; INDZHIKYAN M. G., AJKAKAN KIMIAKAN AMSAGIR, ARM. XIM. ZH., 1980, 33, HO 1, 69-73
作者:BAGDASARYAN G. B.、 AJRIYAN L. SH.、 BADALYAN K. S.、 INDZHIKYAN M. G.
DOI:——
日期:——
Selective reduction of alkynes to cis-alkenes by hydrometallation using [(Ph3P)CuH]6.
作者:John F. Daeuble、Colleen McGettigan、Jeffrey M. Stryker
DOI:10.1016/s0040-4039(00)97371-4
日期:1990.1
Selective reduction of alkynes to the corresponding alkenes is reported using the stable, readily prepared copper(I) hydride reagent, [(Ph3P)CuH]6. Terminal alkynes are reduced at room temperature, unactivated internal alkynes react only at elevated temperature. Disubstituted alkynes with propargyl activation are also reduced, giving cis-olefins selectively. Protection of propargylic alcohol functionality